Nausea, vertigo

Indication for Dimenhydrinate

Population group: Suitable for both men and women, only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Dimenhydrinate is indicated for the prevention of the nausea of the traveler, for the lizards, nausea and vomiting accompanying Meniere’s disease, other conditions, as well as labyrinth interventions.

For this indication, competent medicine agencies globally authorize below treatments:

50-300 mg in 2-3 divided doses daily

Route of admnistration

Rectal

Defined daily dose

50 - 300 mg

Dosage regimen

From 16.667 To 100 mg 3 time(s) per day every day

5 mg/kg in 4 divided doses daily

Route of admnistration

Oral

Defined daily dose

5 - 5 mg per kg of body weight

Dosage regimen

From 1.25 To 1.25 mg per kg of body weight 4 time(s) per day every day

5 mg/kg in 4 divided doses daily

Route of admnistration

Intramuscular

Defined daily dose

5 - 5 mg per kg of body weight

Dosage regimen

From 1.25 To 1.25 mg per kg of body weight 4 time(s) per day every day

Active ingredient

Dimenhydrinate is a theoclate salt of the ethanolamine derivative diphenhydramine. It exhibits reversible competitive antagonism with histamine for the capture of H1 receptors. It has anticholinergic (antimuscarinic) properties that explain the anti-emetic action of the drug in cases of labyrinthial irritation (nausea, vertigo), and the central suppression it causes.

Read more about Dimenhydrinate

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner